An additional advantage of the S3-ACE2 neutralization assay is its ability to evaluate multiple spike variants in parallel using as little as 15 μl of serum, allowing the identification of an individual’s susceptibility to circulating and emerging SARS-CoV-2 viruses, whether after infection or vaccination. Here, ACE2 is linked to infection.